EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Identifying of Ubiquitin-Fold Modifier 1 as a Potential Prognostic Biomarker for Unresectable Pancreatic Cancer by Proteomics Analysis

Juan Wang, Kun Xu, Longjin Xu, Jiaxiao Geng, Chengxin Liu, Xinhang Gu, Xiaodong Li iD

Cancer Management and Research · 2026-02 · Volume 18 · 1-15

DOI: 10.2147/cmar.s573143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Management and Research, 2026-02. Verfasst von Juan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

biomarkerpancreatic cancerprognosisproteomicubiquitin-fold modifier 1

Autor:innen und Institutionen

  • Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China.
  • Department of Colorectal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.
  • Department of Health Inspection and Testing Institute, Shandong Center for Disease Control and Prevention, Jinan, Shandong, People's Republic of China.
  • Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.
  • Department of Radiation Oncology, Gansu Provincial Maternity and Child-Care Hospital (Gansu Provincial Central Hospital), Lanzhou, Gansu, People's Republic of China.

ORCID-Profile: Xiaodong Li

Zitieren

APA

Wang, J., Xu, K., Xu, L., Geng, J., Liu, C., Gu, X., & Li, X. (2026). Identifying of Ubiquitin-Fold Modifier 1 as a Potential Prognostic Biomarker for Unresectable Pancreatic Cancer by Proteomics Analysis. Cancer Management and Research, Volume 18, 1-15. https://doi.org/10.2147/cmar.s573143

Vancouver

Wang J, Xu K, Xu L, Geng J, Liu C, Gu X, et al. Identifying of Ubiquitin-Fold Modifier 1 as a Potential Prognostic Biomarker for Unresectable Pancreatic Cancer by Proteomics Analysis. Cancer Management and Research. 2026;Volume 18:1-15. doi:10.2147/cmar.s573143

BibTeX
@article{Wang2026,
  author = {Wang, Juan and Xu, Kun and Xu, Longjin and Geng, Jiaxiao and Liu, Chengxin and Gu, Xinhang and Li, Xiaodong},
  title = {Identifying of Ubiquitin-Fold Modifier 1 as a Potential Prognostic Biomarker for Unresectable Pancreatic Cancer by Proteomics Analysis},
  journal = {Cancer Management and Research},
  year = {2026},
  volume = {Volume 18},
  pages = {1--15},
  doi = {10.2147/cmar.s573143}
}
Kostenlos starten →